Last reviewed · How we verify
Methoxyethyl Etomidate Hydrochloride
At a glance
| Generic name | Methoxyethyl Etomidate Hydrochloride |
|---|---|
| Sponsor | Ahon Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy (PHASE2)
- A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy (PHASE3)
- Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride (PHASE1)
- Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart (PHASE1)
- Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride (PHASE1)
- Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects (PHASE1)
- Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (PHASE1)
- Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: